Category: Stryker Corp.
Hologic hands former Stryker CEO Steven MacMillan the keys to the corner office, agrees to take on 2 new board members to pacify an activist investor and enlists a new scientific advisor.
Cook Medical rearranges its management, naming Rob Lyles as its new executive vice president.
Cook Medical named Rob Lyles executive vice president, the latest move in a larger management shift at the Indiana medtech maker.
Lyles was formerly vice president of Cook's peripheral intervention division. He has been with the company since 2003 and was named division VP in 2007. Lyles' promotion follows the advancement of Pete Yonkman to president of the Cook Medical. Mark Breedlove, a 19-year veteran of Cook Medical, will succeed Lyles as VP of the peripheral intervention division.
Mako Surgical says it's settled 1 of 2 sets of lawsuits filed by shareholders ahead of its $1.65 billion buyout by Stryker Corp.
Veran Medical Technologies appoints former Stryker CFO Curt Hartman as a member of its board of directors.
Veran Medical Technologies said it has brought in former Stryker (NYSE:SYK) CFO Curt Hartman to join its board of directors.
CEO Josh Kornberg tells MassDevice.com about cleaning house and how bad news for rival Stryker Corp. is helping to reinvigorate Skyline Medical.
When John Kornberg joined then-BioDrain Medical in 2011 as an investor, the company had spent the past decade developing its Streamway surgical waste management device and getting clearance to commercialize it in the U.S. But, Kornberg told MassDevice.com recently, it was quickly apparent that BioDrain was stalled, unable to leverage its 510(k) clearance from the FDA into significant U.S. sales.
A pair of brokers plead guilty to charges of insider trading in Stryker Corp. stock ahead of its 2011 acquisition of Orthovita.
A pair of brokers pleaded guilty to federal insider trading charges yesterday, admitting that they used tips from a former Stryker (NYSE:SYK) marketing executive to make illicit trades ahead of the medical device company's 2011 acquisition of Orthovita.
Mako Surgical's sales drop and losses soar in the midst of its $1.65 billion buyout by Stryker, which compels Mako to withdraw its 2013 financial guidance.